- Home
- PAPL vs CMND Comparison
PAPL vs CMND Comparison
Compare PAPL & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- CMND
- Stock Information
- Founded
- PAPL 2015
- CMND 2017
- Country
- PAPL Canada
- CMND Canada
- Employees
- PAPL N/A
- CMND N/A
- Industry
- PAPL Finance: Consumer Services
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- PAPL Finance
- CMND Health Care
- Exchange
- PAPL Nasdaq
- CMND Nasdaq
- Market Cap
- PAPL 4.4M
- CMND 5.3M
- IPO Year
- PAPL 2023
- CMND N/A
- Fundamental
- Price
- PAPL $0.46
- CMND $1.22
- Analyst Decision
- PAPL Strong Buy
- CMND
- Analyst Count
- PAPL 1
- CMND 0
- Target Price
- PAPL $5.50
- CMND N/A
- AVG Volume (30 Days)
- PAPL 69.4K
- CMND 78.3K
- Earning Date
- PAPL 12-20-2024
- CMND 02-05-2025
- Dividend Yield
- PAPL N/A
- CMND N/A
- EPS Growth
- PAPL N/A
- CMND N/A
- EPS
- PAPL N/A
- CMND N/A
- Revenue
- PAPL $2,688,987.00
- CMND N/A
- Revenue This Year
- PAPL $38.59
- CMND N/A
- Revenue Next Year
- PAPL $61.76
- CMND N/A
- P/E Ratio
- PAPL N/A
- CMND N/A
- Revenue Growth
- PAPL 7.46
- CMND N/A
- 52 Week Low
- PAPL $0.41
- CMND $0.92
- 52 Week High
- PAPL $2.14
- CMND $3.58
- Technical
- Relative Strength Index (RSI)
- PAPL 41.42
- CMND 42.56
- Support Level
- PAPL $0.41
- CMND $1.26
- Resistance Level
- PAPL $0.60
- CMND $1.36
- Average True Range (ATR)
- PAPL 0.05
- CMND 0.11
- MACD
- PAPL 0.00
- CMND -0.02
- Stochastic Oscillator
- PAPL 24.32
- CMND 20.51
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.